Most of us are not used to considering dietary fat as a high source of energy for all-out exercise, athletic activity, and physical labor. Energy from fat has usually been associated with stored fat within the body as a reserve for when carbohydrate energy runs out. Now a 2018 Russian study using cross-country skiers as human subjects determined medium chain fatty acids (MCFA), normally contained in only a few saturated fats, supplied immediate energy during high demand athletic endeavors. These fatty acids don’t get stored as fat, but provide sustained energy. This truth can benefit all of us, not just athletes.
A recent 2018 online survey of type 1 diabetics or their parents and caregivers has opened the door for others to use the ketogenic high-fat, low-carbohydrate, moderate protein diet to ease the burden of insulin injections and improve the day-to-day life of type 1 diabetics, potentially leading to remission. This was a breakthrough study, as the ketogenic diet has proven itself with diabetes type 2 sufferers, but there has been little looked into with keto for diabetes 1 patients. This study's focus was on serious carb production. Its title is Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet, and it was published by Pediatrics, the "official journal" of the AAP (American Academy of Pediatrics). Dr. Lewis First, chief editor of Pediatrics, provided an article listing the top 10 items published by Pediatrics during 2018. This study was at the top of the list as the most popular article in Pediatrics for 2018.
The American Diabetes Association (ADA) just put out a position paper on treating diabetes. It’s focus on treatment and prevention, especially for the increasing incidents of diabetes 2 among youth, demonstrates the willful ignorance of institutions that create medical standards for the medical profession. What is ignored is the potential for treating obesity and diabetes 2 with the high-fat low-carb ketogenic diet, which has proven effective for all the factors leading to diabetes and diabetes 2 itself, even improving the overall health of those afflicted with diabetes 1, the less frequent form of diabetes that requires insulin injections.
Researchers in Brazil recently completed an animal study to determine if virgin coconut oil (VCO) could replace pharmaceutical drugs for reducing obesity and its attendant co-morbid inflammatory and diabetic conditions. The researchers refuted the misguided conventional thinking of saturated fats causing obesity. They wanted to investigate the saturated fat coconut oil as a functional food to replace pharmaceutical drugs currently used for obesity that cause adverse side effects. The Brazilian researchers also expressed concern with the abundant schemes and dietary efforts at reducing calories that are impractical and difficult to maintain, not to mention often unhealthy. Using refined carbohydrates and processed vegetable oils to avoid saturated fat is the lifestyle of the unhealthy, as the standard American diet (SAD) has proven. The researchers used refined carbohydrates to create adiposity in their experimental mice. Refined carbohydrates such as sugar, high fructose corn syrup, and flours used in processed foods are pervasive in our culture and have been recognized by many scientists open to the truth as the real culprits behind obesity, diabetes, and heart disease.